Search

everythinglearnresearchcommunity

for

Search:↓

Inducing survivin in normal tissues can protect against radiation damage.

Vemurafenib causes skin side effects similar to RASopathies, requiring regular skin checks and UVA protection.

The surgery for severe congenital ptosis in children is safe and effective, with good long-term results.

New treatments like nanotechnology show promise in improving skin cancer therapy.

The 11th AICPE Congress in Rimini was a major event in European aesthetic plastic surgery.

Light-based treatment, Photobiomodulation, shows promise for non-invasive skin therapy with few side effects.

The document concludes that inflammation markers can be used in diabetes, vitamin D3 affects immune pathways, hyperthyroidism changes hormone levels, androgen levels help diagnose Adrenocortical Carcinoma, erectile dysfunction is linked to diabetes, hypogonadism is common in HIV-infected males, and hormones can be biomarkers for various conditions.

The modified skin board with channels improves skin graft knife performance.

The review found that basal cell carcinomas on the scalp are not more aggressive than those in other locations.

Combining irinotecan and cetuximab is effective for some metastatic colorectal cancer patients but often causes manageable skin issues.

Cancer survivors often experience worse skin problems from treatment than expected, and working with dermatologists could help improve their condition.

Nilotinib can cause keratosis pilaris, a skin condition.

Chemotherapy can cause various skin reactions, with hair loss being the most common, and proper diagnosis and treatment of these reactions are important.

The cancer drugs bortezomib and lenalidomide cause skin side effects in many patients.

Most children with CNS tumors on targeted therapy had skin reactions, which were generally treatable without stopping the therapy.

Many patients on new leukemia drugs had mild to moderate skin reactions.

Finasteride reduces prostate cancer risk but may increase high-grade tumors and has side effects; biopsy methods have similar outcomes; psychosocial factors affect sexual recovery post-surgery.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

Skin side effects from cancer treatments can lead to changes in therapy and are common, with nail changes being the most frequent.

Chemotherapy often causes hair loss, nail changes, and mouth issues, but these are usually manageable.

Immune checkpoint inhibitors can cause skin issues but are linked to better cancer outcomes.

Long-term use of azole antifungals can cause hair loss, hormonal imbalances, and severe skin reactions.

The document concludes that side effects from Smoothened inhibitor drugs for skin cancer are reversible and can be managed with a team approach to maintain quality of life.

New targeted cancer drugs can cause skin side effects, and managing them requires patient education and timely care.

Clinicians should understand tattoos to manage health issues, as tattoos can cause complications and affect medical assessments.

Certain cancer drugs interact with skin bacteria to cause acne-like rashes.

Skin side effects from CDK4/6 inhibitors in breast cancer patients are generally mild and treatable, allowing most patients to continue treatment.

Targeting NETs may help reduce fibrosis in Crohn's disease.

Gefitinib can cause skin problems, diarrhea, and nausea, but rarely causes severe lung disease or hair loss.

Hormones affect skin aging, and treatments targeting hormonal balance may improve skin health.